Use the Back button in your browser to see the other results of your search or to select another record.
Effect of high-voltage pulsed current plus conventional treatment on acute ankle sprain |
Sandoval MC, Ramirez C, Camargo DM, Salvini TF |
Revista Brasileira de Fisioterapia [Brazilian Journal of Physical Therapy] 2010 May-Jun;14(3):193-199 |
clinical trial |
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
BACKGROUND: The effectiveness of high-voltage pulsed current (HVPC) treatments in humans as a means of controlling edema and post-traumatic pain has not yet been established. OBJECTIVE: To analyze the effects of HVPC plus conventional treatment on lateral ankle sprains. METHODS: This was a randomized, controlled, double-blind clinical trial with three intervention groups: CG (control group with conventional treatment); HVPC- group (conventional treatment plus negative polarity HVPC); HVPC+ group (conventional treatment plus positive polarity HVPC). Twenty-eight participants with lateral ankle sprain (2 to 96 h post-trauma) were evaluated. Conventional treatment consisted of cryotherapy (20 min) plus therapeutic exercises. Additionally, the HVPC- and HVPC+ groups received 30 min of electrical stimulation (submotor level; 120 pps). Pain, edema, range of motion (ROM) and gait were assessed before the first treatment session and after the last treatment session. RESULTS: At the final evaluation, there were no significant differences between groups. Nevertheless, the HVPC- group had greater values in all assessed parameters. The data analysis showed that the HVPC- group had greater reductions in volume and girth, and greater recovery of ROM and gait velocity. This group also reached the end of the treatment (1.7 weeks; range 1.2 to 2.2) faster than the HVPC+ group and the CG (2.2 weeks; range 1.8 to 2.6). CONCLUSIONS: There were no differences between the study groups, but the results suggest that HVPC- can accelerate the initial phase of recovery from ankle sprain. Article registered in the ClinicalTrials.gov under the number NCT00732017.
|